Related Experiment Video
Updated: Aug 6, 2026
Myocardial Infarction and Functional Outcome Assessment in Pigs
Published on: April 25, 2014
Therapy for myocardial infarction: effect on trends in coronary disease mortality
1Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor 48109-0366.
Insights
Hospital mortality after myocardial infarction (MI) has decreased, but valid comparisons require understanding patient population characteristics. Without this data, interpreting MI mortality trends remains challenging.
Area of Science:
- Cardiology
- Public Health
Background:
- Hospital mortality rates following myocardial infarction (MI) have declined since 1950, likely due to therapeutic advancements.
- Accurate international comparisons of MI mortality necessitate understanding patient population characteristics.
Purpose of the Study:
- To highlight the critical need for comprehensive patient data to accurately assess myocardial infarction (MI) mortality trends.
- To emphasize the challenges in interpreting MI mortality data without considering key patient factors.
Main Methods:
- The abstract discusses the importance of assessing various patient factors for valid mortality comparisons.
- Key factors mentioned include age, CCU admission time, thrombolytic use, artery patency, ejection fraction, and smoking status.
Main Results:
- A decrease in hospital mortality post-myocardial infarction (MI) has been observed.
- Valid comparisons and trend analysis are hindered by a lack of detailed patient population data.
Conclusions:
- Understanding patient risk factors (age, comorbidities, lifestyle) is essential before comparing MI mortality rates internationally.
- New therapies like beta-blockers and thrombolysis require population risk factor analysis for accurate trend interpretation.
Abstract:
There has been a gradual decrease in hospital mortality rate following myocardial infarction (MI) since 1950, possibly due to improved therapy. For a valid comparison of mortality rates in various countries, it will, however, be necessary to know the characteristics of the individual patient populations. Factors such as age, time of admission to the CCU, use of thrombolytic agents, patency of the infarct related artery, left ventricular ejection fraction, smoking status as well as conventional risk factors need to be assessed before a valid comparison can be made or conclusions reached concerning trends in mortality after MI. As new and effective therapy for reducing mortality in patients with infarcts are introduced such as Beta blockers, thrombolysis, aspirin, and converting enzyme inhibitors one should be cautious in drawing conclusions as to trends in mortality from the results of clinical trials of these agents until one has a clear understanding of the risk factors of the population studied. Without this information, we may be no closer to an understanding of the cause of changing trends in mortality over the next decade than to understanding the trends over the last two decades.
More Related Videos
14:35Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
05:41Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
Published on: December 16, 2022
Related Concept Videos
01:21Myocarditis I: Introduction
01:14Myocarditis III: Medical Management
01:26Coronary Artery Disease IV: Preventive Measures
01:27Coronary Artery Disease V: Interprofessional Care
01:30Acute Coronary Syndrome I: Introduction
01:28Acute Coronary Syndrome IV: Interprofessional Care